Asthma
Exhaled nitric oxide not useful as diagnostic marker during acute attacks
Published in Immunotherapy Weekly, August 31st, 2005
"Fractional exhaled nitric oxide (FENO) has been shown in laboratory settings and trials of patients with stable asthma to correlate with the degree of airway inflammation," physicians in California explained.
M. Gill and colleagues at the Loma Linda University Medical Center "hypothesized that the technique of measuring FENO would be reproducible in the setting of acute asthma in the emergency department (ED) and that the FENO results during ED visits would potentially predict disposition, predict relapse following discharge, and correlate with the National...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2005-08-31)
More Articles from Immunotherapy Weekly
- Allergy Medicine
Oral tolerance in absence of naturally occurring Tregs examined - Cancer Immunotherapy
Genetic investigations reveal unique tumor antigens - Crohn Disease
CD19+ in intestinal mucosa may predict response to infliximab - Graft-versus-Host Disease
Chronic graft-versus-host disease modeled, nephrin autoantibodies implicated - Adenovirus Vector
Capsid modifications enable flexible targeting of adenovirus vectors - Allergy & Immunology
Activation of innate immune system has role in chemically induced autoimmunity - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
